FRONTIER MEDICINES
Live / Allowed — Notice of allowance issued (as of 03 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 28 Mar 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99108588
- Mark type
- Stylized text
- Filed
- 28 Mar 2025
- Published for opposition
- 09 Dec 2025
- Attorney of record
- Muzamil Huq
Goods and services
- Class 005 — Pharmaceuticals: Small molecule pharmaceuticals for the treatment of heart disease, blood pressure, Alzheimer's disease, arthritis, diabetes, obesity, mitochondrial disease, autoimmune diseases, hypertension, inflammatory bowel disease, amyotrophic lateral sclerosis, neurological diseases, allergies and asthma, hepatic disease, pulmonary disease, renal disease, infectious diseases, pain, peripheral neuropathy, inflammatory disease, autoimmune disease, ulcerative colitis, atopic dermatitis, plaque psoriasis, chronic obstructive pulmonary disease, Crohn's disease, eosinophilic esophagitis, systemic lupus erythematosus, multiple sclerosis, age-related diseases in the nature of Huntington's Disease, rare diseases in the nature of Lysosomal storage disorders, Peroxisomal disorders, Transthyretin Amyloid Cardiopathy (ATTR-CM), Alpha-1 Antitrypsin Deficiency (AATD), ENPP1 deficiency and vitamin D-dependent rickets diseases (VDDR), and pediatric diseases in the nature of Medulloblastoma, Pediatric Acute Lymphoblastic Leukemia (ALL) in humans
Owner
- Frontier Medicines Corporation, South San Francisco, CA, US
- Frontier Medicines Corporation, South San Francisco, CA, US
Prior registrations
Prosecution history
- 03 Feb 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Dec 2025 — PUBLISHED FOR OPPOSITION
- 03 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Nov 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Nov 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Nov 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 03 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 03 Sept 2025 — NON-FINAL ACTION E-MAILED
- 03 Sept 2025 — NON-FINAL ACTION WRITTEN
- 26 Aug 2025 — ASSIGNED TO EXAMINER
- 28 Mar 2025 — APPLICATION FILING RECEIPT MAILED
- 28 Mar 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 28 Mar 2025 — NEW APPLICATION ENTERED